<?xml version="1.0" encoding="UTF-8"?>
<html xmlns="http://www.w3.org/1999/xhtml">
 <head charset="UTF-8"/>
 <style> * { font-family : helvetica;} .font19 { font-size : 19; } .font22 { font-size : 22; } .font10 { font-size : 10; } .font11 { font-size : 11; } .font12 { font-size : 12; } .font13 { font-size : 13; } .font30 { font-size : 30; } .font15 { font-size : 15; }</style>
 <body>
  <p>
   <span class="font30">the </span>
   <span class="font22">and </span>
   <span class="font19">drug </span>
   <span class="font19">for </span>
   <span class="font15">[]. </span>
   <span class="font13">with </span>
   <span class="font13">repositioning </span>
   <span class="font12">that </span>
   <span class="font12">are </span>
   <span class="font12">drugs </span>
   <span class="font12">has </span>
   <span class="font12">Drug </span>
   <span class="font12">The </span>
   <span class="font11">potential </span>
   <span class="font11">which </span>
   <span class="font11">from </span>
   <span class="font11">such </span>
   <span class="font11">new </span>
   <span class="font11">was </span>
   <span class="font11">This </span>
   <span class="font11">diseases </span>
   <span class="font11">treatment </span>
   <span class="font11">this </span>
   <span class="font11">COVID- </span>
   <span class="font11">can </span>
   <span class="font11">been </span>
   <span class="font11">disease </span>
   <span class="font11">have </span>
   <span class="font11">development </span>
   <span class="font11">{background </span>
   <span class="font10">viral </span>
   <span class="font10">approach </span>
   <span class="font10">computational </span>
   <span class="font10">orphan </span>
   <span class="font10">study </span>
   <span class="font10">many </span>
   <span class="font10">other </span>
   <span class="font10">treat </span>
   <span class="font10">For </span>
   <span class="font10">approved </span>
   <span class="font10">clinical </span>
   <span class="font10">studies </span>
   <span class="font10">used </span>
   <span class="font10">margin </span>
   <span class="font10">more </span>
   <span class="font10">patients </span>
   <span class="font10">targets </span>
   <span class="font10">against </span>
   <span class="font10">{border-style </span>
   <span class="font10">HIV </span>
   <span class="font10">especially </span>
   <span class="font10">SARS-CoV- </span>
   <span class="font10">data </span>
   <span class="font10">existing </span>
   <span class="font10">not </span>
   <span class="font10">px;} </span>
   <span class="font10">successfully </span>
   <span class="font10">#ffffff;} </span>
   <span class="font10">instance, </span>
   <span class="font10">its </span>
   <span class="font10">molecular </span>
   <span class="font10">time </span>
   <span class="font10">were </span>
   <span class="font10">where </span>
   <span class="font10">discovery </span>
   <span class="font10">repositioned </span>
   <span class="font10">target </span>
   <span class="font10">via </span>
   <span class="font10">cell </span>
   <span class="font10">different </span>
   <span class="font10">repositioning. </span>
   <span class="font10">there </span>
   <span class="font10">HCQ </span>
   <span class="font10">also </span>
   <span class="font10">antiviral </span>
   <span class="font10">approaches </span>
   <span class="font10">docking </span>
   <span class="font10">gene </span>
   <span class="font10">may </span>
   <span class="font10">novel </span>
   <span class="font10">trials </span>
   <span class="font10">GWAS </span>
   <span class="font10">With </span>
   <span class="font10">compared </span>
   <span class="font10">high </span>
   <span class="font10">intended </span>
   <span class="font10">protein </span>
   <span class="font10">research </span>
   <span class="font10">than </span>
   <span class="font10">Repositioning </span>
   <span class="font10">candidates </span>
   <span class="font10">chemical </span>
   <span class="font10">due </span>
   <span class="font10">effective </span>
   <span class="font10">expression </span>
   <span class="font10">low </span>
   <span class="font10">methods </span>
   <span class="font10">pharmaceutical </span>
   <span class="font10">rare </span>
   <span class="font10">reported </span>
   <span class="font10">significant </span>
   <span class="font10">significantly </span>
   <span class="font10">therapeutic </span>
   <span class="font10">However, </span>
   <span class="font10">available </span>
   <span class="font10">genes </span>
   <span class="font10">known </span>
   <span class="font10">process </span>
   <span class="font10">specific </span>
   <span class="font10">their </span>
   <span class="font10">Auranofin </span>
   <span class="font10">[,]. </span>
   <span class="font10">based </span>
   <span class="font10">combination </span>
   <span class="font10">current </span>
   <span class="font10">developed </span>
   <span class="font10">discovered </span>
   <span class="font10">drugs, </span>
   <span class="font10">infection </span>
   <span class="font10">inhibitor </span>
   <span class="font10">into </span>
   <span class="font10">lack </span>
   <span class="font10">now </span>
   <span class="font10">over </span>
   <span class="font10">similar </span>
   <span class="font10">use </span>
   <span class="font10">when </span>
   <span class="font10">Also, </span>
   <span class="font10">COVID-. </span>
   <span class="font10">FDA </span>
   <span class="font10">Med. </span>
   <span class="font10">Rev. </span>
   <span class="font10">accompanied </span>
   <span class="font10">action </span>
   <span class="font10">associated </span>
   <span class="font10">being </span>
   <span class="font10">conducted </span>
   <span class="font10">efficacy </span>
   <span class="font10">hair </span>
   <span class="font10">human </span>
   <span class="font10">inhibiting </span>
   <span class="font10">involves </span>
   <span class="font10">most </span>
   <span class="font10">repurposing </span>
   <span class="font10">result </span>
   <span class="font10">safety </span>
   <span class="font10">subsequently </span>
   <span class="font10">therapy </span>
   <span class="font10">through </span>
   <span class="font10">traditional </span>
   <span class="font10">treatments </span>
   <span class="font10">two </span>
   <span class="font10">vitro </span>
   <span class="font10">within </span>
   <span class="font10">Apart </span>
   <span class="font10">Cushingâ€™s </span>
   <span class="font10">New </span>
   <span class="font10">RNA </span>
   <span class="font10">companies </span>
   <span class="font10">cost </span>
   <span class="font10">database </span>
   <span class="font10">diseases, </span>
   <span class="font10">drug, </span>
   <span class="font10">effect </span>
   <span class="font10">effects </span>
   <span class="font10">failure </span>
   <span class="font10">genetic </span>
   <span class="font10">highly </span>
   <span class="font10">inhibitors </span>
   <span class="font10">interest </span>
   <span class="font10">lung </span>
   <span class="font10">mechanism </span>
   <span class="font10">old </span>
   <span class="font10">outcome </span>
   <span class="font10">px; </span>
   <span class="font10">repositioning, </span>
   <span class="font10">respiratory </span>
   <span class="font10">shown </span>
   <span class="font10">some </span>
   <span class="font10">these </span>
   <span class="font10">virus </span>
   <span class="font10">{font-family </span>
   <span class="font10">Discov. </span>
   <span class="font10">Everolimus </span>
   <span class="font10">after </span>
   <span class="font10">al. </span>
   <span class="font10">already </span>
   <span class="font10">analysis </span>
   <span class="font10">biological </span>
   <span class="font10">cancer </span>
   <span class="font10">candidate </span>
   <span class="font10">consideration </span>
   <span class="font10">crucial </span>
   <span class="font10">databases </span>
   <span class="font10">example </span>
   <span class="font10">factors </span>
   <span class="font10">font-size </span>
   <span class="font10">identified </span>
   <span class="font10">information </span>
   <span class="font10">initially </span>
   <span class="font10">investment </span>
   <span class="font10">kinase </span>
   <span class="font10">multiple </span>
   <span class="font10">novo </span>
   <span class="font10">overall </span>
   <span class="font10">proteins </span>
   <span class="font10">results </span>
   <span class="font10">role </span>
   <span class="font10">several </span>
   <span class="font10">small </span>
   <span class="font10">treatment. </span>
   <span class="font10">under </span>
   <span class="font10">years </span>
   <span class="font10">... </span>
   <span class="font10">Clin. </span>
   <span class="font10">Discov../nrd </span>
   <span class="font10">NSCLC </span>
   <span class="font10">One </span>
   <span class="font10">There </span>
   <span class="font10">activity </span>
   <span class="font10">acute </span>
   <span class="font10">approach, </span>
   <span class="font10">aside </span>
   <span class="font10">billion </span>
   <span class="font10">binding </span>
   <span class="font10">but </span>
   <span class="font10">compounds </span>
   <span class="font10">coronavirus </span>
   <span class="font10">costs </span>
   <span class="font10">currently </span>
   <span class="font10">double; </span>
   <span class="font10">drugs. </span>
   <span class="font10">established </span>
   <span class="font10">few </span>
   <span class="font10">found </span>
   <span class="font10">growth </span>
   <span class="font10">large </span>
   <span class="font10">less </span>
   <span class="font10">loss </span>
   <span class="font10">molecules </span>
   <span class="font10">number </span>
   <span class="font10">ongoing </span>
   <span class="font10">only </span>
   <span class="font10">particular </span>
   <span class="font10">pathway </span>
   <span class="font10">patient </span>
   <span class="font10">personalised </span>
   <span class="font10">positive </span>
   <span class="font10">promising </span>
   <span class="font10">recent </span>
   <span class="font10">receptor </span>
   <span class="font10">replication </span>
   <span class="font10">resistant </span>
   <span class="font10">risk </span>
   <span class="font10">success </span>
   <span class="font10">that, </span>
   <span class="font10">then </span>
   <span class="font10">thus </span>
   <span class="font10">uric </span>
   <span class="font10">various </span>
   <span class="font10">year </span>
   <span class="font10">yet </span>
   <span class="font10">Coronavirus </span>
   <span class="font10">Diseases </span>
   <span class="font10">Duloxetine </span>
   <span class="font10">Future </span>
   <span class="font10">Heme </span>
   <span class="font10">Korlym </span>
   <span class="font10">Multiple </span>
   <span class="font10">Orphan </span>
   <span class="font10">Repurposing </span>
   <span class="font10">Sildenafil </span>
   <span class="font10">Subsequently, </span>
   <span class="font10">Thalidomide </span>
   <span class="font10">Today./j.drudis... </span>
   <span class="font10">Treatment </span>
   <span class="font10">acid </span>
   <span class="font10">across </span>
   <span class="font10">advancement </span>
   <span class="font10">advantage </span>
   <span class="font10">all </span>
   <span class="font10">always </span>
   <span class="font10">anticancer </span>
   <span class="font10">better </span>
   <span class="font10">between </span>
   <span class="font10">border-color </span>
   <span class="font10">border-width </span>
   <span class="font10">cells </span>
   <span class="font10">challenges </span>
   <span class="font10">chronic </span>
   <span class="font10">collaboration </span>
   <span class="font10">common </span>
   <span class="font10">complex </span>
   <span class="font10">coronary </span>
   <span class="font10">deep </span>
   <span class="font10">demand </span>
   <span class="font10">design </span>
   <span class="font10">developmental </span>
   <span class="font10">diseases. </span>
   <span class="font10">driven </span>
   <span class="font10">each </span>
   <span class="font10">early </span>
   <span class="font10">evaluated </span>
   <span class="font10">factor </span>
   <span class="font10">followed </span>
   <span class="font10">further </span>
   <span class="font10">genome </span>
   <span class="font10">glucocorticoid </span>
   <span class="font10">heart </span>
   <span class="font10">important </span>
   <span class="font10">include </span>
   <span class="font10">inhibitor, </span>
   <span class="font10">initial </span>
   <span class="font10">levels </span>
   <span class="font10">life </span>
   <span class="font10">like </span>
   <span class="font10">limitations </span>
   <span class="font10">load </span>
   <span class="font10">method </span>
   <span class="font10">need </span>
   <span class="font10">network </span>
   <span class="font10">online: </span>
   <span class="font10">opportunities </span>
   <span class="font10">original </span>
   <span class="font10">prediction </span>
   <span class="font10">prime </span>
   <span class="font10">respect </span>
   <span class="font10">reverse </span>
   <span class="font10">same </span>
   <span class="font10">screening </span>
   <span class="font10">side-effects </span>
   <span class="font10">signature </span>
   <span class="font10">solid; </span>
   <span class="font10">strategy </span>
   <span class="font10">structure </span>
   <span class="font10">symptoms </span>
   <span class="font10">syndrome </span>
   <span class="font10">they </span>
   <span class="font10">toxic </span>
   <span class="font10">transcriptase </span>
   <span class="font10">upon </span>
   <span class="font10">urgent </span>
   <span class="font10">uses </span>
   <span class="font10">vast </span>
   <span class="font10">well </span>
   <span class="font10">who </span>
   <span class="font10">{font-style </span>
   <span class="font10">{font-weight </span>
   <span class="font10">Acad. </span>
   <span class="font10">Another </span>
   <span class="font10">Baricitinib </span>
   <span class="font10">Bioinform../bib/bbr </span>
   <span class="font10">COVID-, </span>
   <span class="font10">Chloroquine </span>
   <span class="font10">Computational </span>
   <span class="font10">Concerta </span>
   <span class="font10">FDA-approved </span>
   <span class="font10">Figure </span>
   <span class="font10">Human </span>
   <span class="font10">Infect. </span>
   <span class="font10">March </span>
   <span class="font10">Minoxidil </span>
   <span class="font10">Novel </span>
   <span class="font10">Pathway </span>
   <span class="font10">Rapamycin </span>
   <span class="font10">Recently, </span>
   <span class="font10">Remdesivir </span>
   <span class="font10">Repositioning: </span>
   <span class="font10">Research </span>
   <span class="font10">Sildenafil, </span>
   <span class="font10">TSC </span>
   <span class="font10">Table </span>
   <span class="font10">Tuberous </span>
   <span class="font10">U.S. </span>
   <span class="font10">Virus </span>
   <span class="font10">active </span>
   <span class="font10">activities </span>
   <span class="font10">advanced </span>
   <span class="font10">aforementioned </span>
   <span class="font10">agent </span>
   <span class="font10">aid </span>
   <span class="font10">almost </span>
   <span class="font10">alternative </span>
   <span class="font10">another </span>
   <span class="font10">approach. </span>
   <span class="font10">approval </span>
   <span class="font10">approximately </span>
   <span class="font10">arthritis </span>
   <span class="font10">associations </span>
   <span class="font10">before </span>
   <span class="font10">benefits </span>
   <span class="font10">blood </span>
   <span class="font10">bold </span>
   <span class="font10">cancers </span>
   <span class="font10">carried </span>
   <span class="font10">certain </span>
   <span class="font10">colleagues </span>
   <span class="font10">company </span>
   <span class="font10">considered </span>
   <span class="font10">courier; </span>
   <span class="font10">date, </span>
   <span class="font10">disease, </span>
   <span class="font10">disease. </span>
   <span class="font10">disorder </span>
   <span class="font10">drug. </span>
   <span class="font10">drugâ€"disease </span>
   <span class="font10">effort </span>
   <span class="font10">em; </span>
   <span class="font10">enhanced </span>
   <span class="font10">erectile </span>
   <span class="font10">even </span>
   <span class="font10">example, </span>
   <span class="font10">examples </span>
   <span class="font10">extensive </span>
   <span class="font10">first </span>
   <span class="font10">generated </span>
   <span class="font10">genome-wide </span>
   <span class="font10">global </span>
   <span class="font10">had </span>
   <span class="font10">increases </span>
   <span class="font10">increasing </span>
   <span class="font10">infection, </span>
   <span class="font10">key </span>
   <span class="font10">learning </span>
   <span class="font10">limitation </span>
   <span class="font10">lymphoma </span>
   <span class="font10">machine </span>
   <span class="font10">made </span>
   <span class="font10">make </span>
   <span class="font10">market </span>
   <span class="font10">medical </span>
   <span class="font10">might </span>
   <span class="font10">namely </span>
   <span class="font10">needed </span>
   <span class="font10">occurs </span>
   <span class="font10">one </span>
   <span class="font10">outbreak </span>
   <span class="font10">outbreaks </span>
   <span class="font10">pandemic </span>
   <span class="font10">parasite </span>
   <span class="font10">plays </span>
   <span class="font10">possible </span>
   <span class="font10">potent </span>
   <span class="font10">preclinical </span>
   <span class="font10">preventing </span>
   <span class="font10">primarily </span>
   <span class="font10">production </span>
   <span class="font10">profile </span>
   <span class="font10">profiles </span>
   <span class="font10">projects </span>
   <span class="font10">projects, </span>
   <span class="font10">providing </span>
   <span class="font10">pt;} </span>
   <span class="font10">reduced </span>
   <span class="font10">resistance </span>
   <span class="font10">review </span>
   <span class="font10">rheumatoid </span>
   <span class="font10">sclerosis </span>
   <span class="font10">search </span>
   <span class="font10">set </span>
   <span class="font10">severe </span>
   <span class="font10">study, </span>
   <span class="font10">sulphate </span>
   <span class="font10">treatment, </span>
   <span class="font10">urinary </span>
   <span class="font10">usage </span>
   <span class="font10">using </span>
   <span class="font10">will </span>
  </p>
 </body>
</html>
